As DNA sequencing commemorates its 40th anniversary, advancements are being made toward third-generation sequencing tools with an ultimate goal of achieving precise real-time products.
The latest NGS systems are now capable of producing nearly 100,000-fold more sequencing data per run as compared to initial NGS systems launched 10 years ago.
NGS tools have the potential to allow for revolutionary science, including direct sequencing of RNA or proteins, real-time genomic pathogen monitoring, or precision medicine based on personal genome sequencing.
Despite opening a new edge of genomics research, the fundamental shift away from the conventional sequencing to the NGS technologies has left many undiscovered applications and capabilities of these new technologies, especially those in clinical segment.
Competition intensifies as vendors make inroads into emerging markets.
Multiple sequencing platforms released over the past decade have opened doors to high-throughput high-sensitivity quick whole genome sequencing.